Endoart SA, a Swiss company which develops medical devices for the obese, said it has raised CHF13.5 million ($10.5 million) in a series C financing from venture capital funds for product development and clinical trials.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.